William B. Greenough III (* January 3rd 1932 in Providence (Rhode Iceland) ) is an American physician. He is a specialist in the treatment of diarrheal diseases such as cholera in the Third World.
Greenough studied chemistry at Amherst College (Bachelor 1953) and medicine at Harvard Medical School (MD 1957). 1962 to 1965, he served as surgeon for the U.S. National Public Health Service (USNHS) when cholera research laboratory in Dhaka ( Bangladesh ) and then to 1967 at the National Institutes of Health (NIH). 1967 to 1969 he was assistant professor of medicine at Johns Hopkins University (and urban hospitals in Baltimore) and 1969 to 1983 he was associate professor of medicine there and microbiology. At the same time, he was from 1970 to 1976 head of infectious diseases at Johns Hopkins Hospital (and at the same time the NIAID  of the NIH, the Bacteriology and Mycology department, he 1974-1976 board) and 1977-1979 academic director of the Cholera Research Centre in Dhaka (whose advice He also later board). 1979 to 1985 he was head of the International Centre for Diarrhoeal Disease Research in Dhaka. Since 1984, he has a full professor of medicine at Johns Hopkins University. He is there in geriatrics at Johns Hopkins Bayview Medical Center and Professor of International Health at the Bloomberg School of Public Health at Johns Hopkins. In geriatric medicine he was taking part in a long-term program for home care (hospital at home), where he applied his extensive experience from developing countries (for example in the Rehydrierungsbehandlung and generally poorer in the treatment of the population with low costs).
He dealt with cholera research and examined the mechanisms of action of the votes cast by the cholera bacteria toxin . He was also in the development of effective methods of oral fluid intake (Oral Rehydration Therapy ORT) involved in cholera and other diarrheal diseases  , especially under conditions of the Third World (see WHO drinking solution ). The development of an oral therapy was then a novel idea, although the problems in the use of intravenous hydration were evident in the Third World. Greenough was in the development of ORT part of a group of U.S. physicians in the 1960s in Bangladesh.  In the late 1970s he was also the development of a rice-based ORT for developing countries involved (a suggestion from Michael Field following)  .
In 1983 he was awarded with John S. Fordtran and Michael Field the King Faisal Prize in Medicine for research on diarrheal diseases. With field he worked in the early 1970s on the effect of cholera toxin together  . In 1984 he received the Maurice Pate Prize of UNICEF . In 2001 he held the Howard Florey Medal Lecture in Adelaide .
Beastly questions. (use of animals in medical research) (Contested Terrain) (column): An article from: The Hastings Center Report
Book (Hastings Center)
Continued2010-01-23 13:21:28 by Darwinian_Devil
Founded in 1985, PCRM is a nonprofit organization supported by physicians and laypersons who receive Good Medicine each quarter. PCRM programs combine the efforts of medical experts and grassroots individuals.
PCRM Board of Directors: Neal D. Barnard, M.D., President; Mark Sklar, M.D., Director; Russell Bunai, M.D., Treasurer and Secretary.
PCRM’s advisory board includes 11 health care professionals from a broad range of specialties:
T. Colin Campbell, Ph.D. Cornell University
Caldwell B. Esselstyn, Jr., M
You might also like:
$25m to move medical school — The Canberra Times
Plans are being drafted to refurbish the old heritage-listed John Curtin school of medical research, which was vacated in 2011, and to build a new $144 million state-of-the-art custom-built research centre next door.
Big Ten schools make strides in medical, agricultural research — Daily Nebraskan
Up north, the University of Minnesota-Twin Cities recently opened its new simulation center for the School of Nursing and the University of Wisconsin-Madison began a five-year research project on the dairy process.
Thorne Research Veterinary - Small Animal Anti-Oxidant - 120 caps
Pet Products (Thorne Research Veterinary)
Commercially-Available Drug to be Tested in Severe Form of Autism — Newswise
Newswise — Scientists at the Seaver Autism Center at the Icahn School of Medicine at Mount Sinai have received a grant from the National Institutes of Health (NIH) to study Insulin-Like Growth Factor-1 (IGF-1), a promising treatment for a subtype of ..
Transgenic Animals: Proceedings of the Symposium on Transgenic Technology in Medicine and Agriculture (Biotechnology Series)
Aping Science: A Critical Analysis of Research at the Yerkes Regional Primate Research Center.
Book (New York: Medical Research Modernization Committee 1995.)
Policy issues in the use of animals in research, testing, and education. (section 5) (Animals, Science, and Ethics): An article from: The Hastings Center Report
Book (Hastings Center)